U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H11N2O2S.Cu
Molecular Weight 298.828
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALLOCUPREIDE

SMILES

[Cu+].[O-]C(=O)C1=CC=CC(NC(=S)NCC=C)=C1

InChI

InChIKey=ZZDFYPGVZZDZBL-UHFFFAOYSA-M
InChI=1S/C11H12N2O2S.Cu/c1-2-6-12-11(16)13-9-5-3-4-8(7-9)10(14)15;/h2-5,7H,1,6H2,(H,14,15)(H2,12,13,16);/q;+1/p-1

HIDE SMILES / InChI

Description

Allocupreide is a copper(l) complex used as an antiinflammatory drug and antiarthritic agent. It was used for the treatment of trigeminal neuralgia.

Originator

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
The role of the anaesthetist in the treatment of tic douloureux.
1955-07
A case of trigeminal neuralgia treated with cuproallyl-thiourea-sodium-benzoate.
1951-09
Trigeminal neuralgia treated with cuprelone.
1948-10-30
Patents

Patents

DE551421
2

Sample Use Guides

In Vivo Use Guide
Cuprelone (Allocupreide) has been tried in 100 mg doses intravenously twice weekly for a month.
Route of Administration: Intravenous
Name Type Language
ALLOCUPREIDE
Common Name English
3-(3-ALLYL-S-CUPROPSEUDOTHIOUREIDO)BENZOATE
Preferred Name English
BENZOIC ACID, 3-(((2-PROPEN-1-YLAMINO)THIOXOMETHYL)AMINO)-, COPPER(1+)
Systematic Name English
Code System Code Type Description
PUBCHEM
73951933
Created by admin on Mon Mar 31 21:58:10 GMT 2025 , Edited by admin on Mon Mar 31 21:58:10 GMT 2025
PRIMARY
FDA UNII
ZH635E3D4S
Created by admin on Mon Mar 31 21:58:10 GMT 2025 , Edited by admin on Mon Mar 31 21:58:10 GMT 2025
PRIMARY
SUBSTANCE RECORD
Structure of ALLOCUPREIDE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966